Rapid Micro Biosystems (NASDAQ:RPID) Releases Earnings Results, Beats Expectations By $0.01 EPS

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) released its quarterly earnings data on Friday, May 9th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.01, Zacks reports. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. The firm had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Performance

Shares of Rapid Micro Biosystems stock traded up $0.15 during trading on Friday, hitting $3.21. 131,114 shares of the stock were exchanged, compared to its average volume of 187,524. Rapid Micro Biosystems has a 12 month low of $0.58 and a 12 month high of $4.04. The stock's fifty day moving average is $2.42 and its 200 day moving average is $1.90. The stock has a market cap of $138.79 million, a PE ratio of -2.87 and a beta of 1.13.

Wall Street Analyst Weigh In

Separately, KeyCorp initiated coverage on Rapid Micro Biosystems in a report on Wednesday, February 12th. They issued an "overweight" rating and a $8.00 price target on the stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.